SAN ANTONIO, TX (October 27, 2015) — With the DARA BioSciences, Inc. (Nasdaq: DARA) announcement of the U.S. launch of Oravig® (miconazole), the first and only orally- dissolving muco-adhesive buccal tablet approved to treat adults with oral thrush, Mission Pharmacal Company has further demonstrated its unique partnering strategy to help patients obtain needed medication.
DARA Biosciences, Midatech Pharma to Merge